These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3123936)

  • 1. Dimeric opioid antagonists.
    Thornber CW; Shaw JS; Miller L; Hayward CF
    NIDA Res Monogr; 1986; 75():181-4. PubMed ID: 3123936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyprodime analogues: synthesis and pharmacological evaluation.
    Schmidhammer H; Smith CF; Erlach D; Koch M; Krassnig R; Schwetz W; Wechner C
    Prog Clin Biol Res; 1990; 328():37-40. PubMed ID: 2154795
    [No Abstract]   [Full Text] [Related]  

  • 3. New delta-receptor antagonists.
    Thornber CW; Shaw JS; Miller L; Hayward CF; Morley JS; Timms D; Wilkinson A
    NIDA Res Monogr; 1986; 75():177-80. PubMed ID: 2828968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
    J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM
    Receptor; 1994; 4(1):43-53. PubMed ID: 8038706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cyclic enkephalin analogue with potent opioid antagonist activity.
    Weltrowska G; Lu Y; Lemieux C; Chung NN; Schiller PW
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4731-3. PubMed ID: 15324897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Arylidenenaltrexones as selective delta1 opioid receptor antagonists.
    Ohkawa S; Portoghese PS
    J Med Chem; 1998 Oct; 41(21):4177-80. PubMed ID: 9767654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity.
    Goldstein A; James IF
    Mol Pharmacol; 1984 May; 25(3):343-8. PubMed ID: 6328260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 11. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats.
    Schiller PW; Fundytus ME; Merovitz L; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Coderre TJ
    J Med Chem; 1999 Sep; 42(18):3520-6. PubMed ID: 10479285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of selective tolerance to particular types of opiate receptors.
    Herz A; Schulz R; Wuster M
    NIDA Res Monogr; 1982 Apr; 41():215-22. PubMed ID: 6289118
    [No Abstract]   [Full Text] [Related]  

  • 14. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
    Schulz R; Wüster M; Herz A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a single opioid receptor type on the rat deferens.
    Freer RJ; Day AR; Liao CS
    NIDA Res Monogr; 1982 Apr; 41():172-7. PubMed ID: 6289116
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH; Davis P; Hruby VJ; Burks TF; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):577-84. PubMed ID: 8394911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptors.
    Bishop MJ; Garrido DM; Boswell GE; Collins MA; Harris PA; McNutt RW; O'Neill SJ; Wei K; Chang KJ
    J Med Chem; 2003 Feb; 46(4):623-33. PubMed ID: 12570383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
    J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
    Makó E; Rónai AZ
    Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.